The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, Z.
Right arrow Articles by Gupta, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, Z.
Right arrow Articles by Gupta, D.
The Journal of Immunology, 2001, 167: 6975-6982.
Copyright © 2001 by The American Association of Immunologists

Bacterial Peptidoglycan-Induced tnf-{alpha} Transcription Is Mediated Through the Transcription Factors Egr-1, Elk-1, and NF-{kappa}B1

Zhaojun Xu*, Roman Dziarski*, Qiuling Wang2,*, Kevin Swartz*, Kathleen M. Sakamoto{dagger} and Dipika Gupta3,*

* Northwest Center for Medical Education, Indiana University School of Medicine, Gary, IN 46408; and {dagger} Departments of Pediatrics and Pathology, University of California, Los Angeles, School of Medicine, Los Angeles, CA 90095


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Bacteria and their ubiquitous cell wall component peptidoglycan (PGN) activate the innate immune system of the host and induce the release of inflammatory molecules. TNF-{alpha} is one of the highest induced cytokines in macrophages stimulated with PGN; however, the regulation of tnf-{alpha} expression in PGN-activated cells is poorly understood. This study was done to identify some of the transcription factors that regulate the expression of the tnf-{alpha} gene in macrophages stimulated with PGN. Our results demonstrated that PGN-induced expression of human tnf-{alpha} gene is regulated by sequences proximal to -182 bp of the promoter. Mutations within the binding sites for cAMP response element, early growth response (Egr)-1, and {kappa}B3 significantly reduced this induction. The transcription factor c-Jun bound the cAMP response element site, Egr-1 bound the Egr-1 motif, and NF-{kappa}B p50 and p65 bound to the {kappa}B3 site on the tnf-{alpha} promoter. PGN rapidly induced transcription of egr-1 gene and this induction was significantly reduced by specific mutations within the serum response element-1 domain of the egr-1 promoter. PGN also induced phosphorylation and activation of Elk-1, a member of the Ets family of transcription factors. Elk-1 and serum response factor proteins bound the serum response element-1 domain on the egr-1 promoter, and PGN-induced expression of the egr-1 was inhibited by dominant-negative Elk-1. These results indicate that PGN induces activation of the transcription factors Egr-1 and Elk-1, and that PGN-induced expression of tnf-{alpha} is directly mediated through the transcription factors c-Jun, Egr-1, and NF-{kappa}B, and indirectly through the transcription factor Elk-1.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
Bacteria activate the innate immune system of the host and induce the release of inflammatory molecules such as chemokines and cytokines (1, 2). Peptidoglycan (PGN)4 and LPS, the main cell wall components of Gram-positive and Gram-negative bacteria, respectively, activate the innate immune system of the host and induce the release of chemokines and cytokines (3, 4). These inflammatory molecules are the primary cause of the various signs and symptoms seen during bacterial infections, including fever, inflammation, and acute phase response (3, 4).

We have previously shown that PGN activates host cells through the pattern recognition receptors Toll-like receptor (TLR)2 (5, 6) and CD14 (7, 8, 9), and induces the expression of over 120 genes in human monocytes (10). The highest induced genes include chemokines (IL-8, macrophage inflammatory protein-1, macrophage inflammatory protein-2, and monocyte chemoattractant protein) and cytokines (TNF-{alpha}, IL-1, and IL-6) (10). We have shown that PGN-induced expression of IL-8 is mediated through TLR2 and requires the signal transduction molecules myeloid differentiation protein (MyD88), IL-1R-associated kinase (IRAK), NF-{kappa}B-inducing kinase (NIK), I{kappa}B kinase (IKK), and the transcription factor NF-{kappa}B (11). We have also shown that PGN induces transcription of tnf-{alpha} gene (10, 12) and secretion of TNF-{alpha} (12). However, nothing is known about the signal transduction molecules or transcription factors that regulate the induction of tnf-{alpha} gene by PGN.

The regulation of human tnf-{alpha} expression is complex and different for different stimulants and different cell types. TNF-{alpha} expression is controlled at both transcriptional and translational levels (13). Translational regulation of TNF-{alpha} mRNA is mediated by a short AU-rich sequence that is present in the 3'-untranslated region (14). However, the primary mechanism of TNF-{alpha} induction in macrophages is at the transcriptional level (15). The expression of tnf-{alpha} in LPS-induced cells has been extensively studied, but it is still not completely elucidated and the results are often conflicting. The promoter of human tnf-{alpha} gene contains potential binding sites for a complex array of transcription factors. LPS-induced tnf-{alpha} transcription appears to be regulated by sequences in the distal region from -650 to -487 bp and by sequences proximal to the -182-bp region of the tnf-{alpha} promoter. Sequences in the distal region of the tnf-{alpha} promoter contain three NF-{kappa}B-like motifs which bind NF-{kappa}B and are involved in LPS-induced tnf-{alpha} expression in the human monocyte cell line Mono Mac 6 (16). In the distal region there is also a binding site for a novel transcription factor, LPS-induced TNF-{alpha} factor, which may contribute to the induction of tnf-{alpha} expression in monocytes (17). However, this region does not regulate LPS-induced tnf-{alpha} expression in all cell types (18). Sequences proximal to -182 bp on the tnf-{alpha} promoter contain motifs for many transcription factors, including activating protein (AP)-1, AP-2, cAMP response element (CRE), early growth response (Egr)-1, NF-IL6, NF-{kappa}B, and Sp1. LPS activation of macrophages induces binding of transcription factors c-Jun, activating transcription factor (ATF)-2, NF-{kappa}B and Egr-1 to binding sites in the proximal -182-bp region, and mutations within the binding sites for CRE, Egr-1, and NF-{kappa}B inhibit LPS-induced expression of tnf-{alpha} (18, 19).

We have previously shown PGN-induced activation of the transcription factors NF-{kappa}B, CREB, ATF-1, and AP-1, and we have shown activation of the mitogen-activated protein (MAP) kinases extracellular signal-regulated kinase (ERK)1, ERK2, and c-Jun N-terminal kinase (JNK) (12, 20). We have also determined that NF-{kappa}B is activated through the signal transduction pathway MyD88->IRAK->TNFR associated kinase (TRAF)6->NIK->IKK (11). Activation of AP-1 is consistent with the activation of MAP kinases, as JNK activates c-Jun, and both JNK and ERK can induce c-Fos through activation of the ternary complex factor (21). However, the regulation of tnf-{alpha} expression and specifically the role of these transcription factors and signal transduction pathways in PGN-induced expression of tnf-{alpha} is unknown.

Therefore, the objectives of this study were to identify regulatory sequences within the tnf-{alpha} promoter and to determine the role of specific transcription factors in the induced expression of tnf-{alpha} in PGN-activated macrophages. One of the transcription factors identified in this study is the immediate-early growth response transcription factor, Egr-1. Egr-1 is a zinc finger protein that is rapidly induced in diverse cell types following cell activation by a variety of stimulants, including mitogens, cell differentiating agents, and LPS (18, 22). To identify potential signal transduction pathway(s) that regulate expression of tnf-{alpha} through the activation of Egr-1, in this study we further investigated the regulation of Egr-1 in PGN-activated macrophages.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Materials

Soluble PGN (sPGN), a polymeric uncross-linked PGN (average Mr = 125,000), released from Staphylococcus aureus grown in the presence of penicillin, was purified by vancomycin affinity chromatography and analyzed as before (23). Micrococcus luteus (American Type Culture Collection, Manassas, VA; ATCC 4698) was used as a prototypic Gram-positive nonpathogenic (i.e., easily eliminated by the host innate immune system) bacterium with unmodified unsubstituted PGN readily accessible on its surface. sPGN and Micrococcus contained <24 pg and <500 pg endotoxin/mg, respectively, determined by the Limulus lysate assay (23). Protein-free LPS from Salmonella minnesota Re 595 (ReLPS, a minimal naturally occurring endotoxic structure of LPS) obtained by phenol-chloroform-petroleum ether extraction, was purchased from Sigma (St. Louis, MO). sPGN, Micrococci, and LPS were used at optimal stimulatory concentrations (10 µg/ml, 40 µg/ml, and 10 ng/ml, respectively). All other chemicals were from Sigma-Aldrich (St. Louis, MO), unless otherwise indicated.

Cell culture and TNF-{alpha} assay

Murine macrophage RAW264.7 cell line, obtained from American Type Culture Collection, was cultured in DMEM with 10% defined FCS (HyClone Laboratories, Logan, UT; endotoxin content <6 pg/ml). Human monocytic cell lines THP-1 expressing hCD14 (THP-1/hCD14) were obtained from P. Tobias (The Scripps Research Institute, La Jolla, CA) and cultured as described previously (10). To determine whether there was any effect of serum on the activation of Egr-1 and Elk-1, Northern analysis of Egr-1 mRNA and phosphorylation of Elk-1 were initially performed in the presence and absence of serum. For serum-free experiments, all serum was removed from the cells 12 h before stimulation. There was no difference in the results between the serum and serum-free experiments; therefore, all data presented are from experiments carried out in the presence of serum. TNF-{alpha} concentrations in culture supernatants were determined using the L929 cytotoxicity assay as described previously (12).

Plasmids

The plasmids with serial deletions in the tnf-{alpha} promoter, pTNF(-615)Luc, pTNF(-295)Luc, pTNF(-95)Luc, and pTNF(-36)Luc, and the mutants CREm, AP-1m, and AP-2m in pTNF(-615)Luc were provided by Dr. J. Economou (24). The plasmids pTNF(-182)Luc, pTNF(-161)Luc, and the mutants Egr-1m and {kappa}B3m in pTNF(-615)Luc were provided by Dr. N. Mackman (18). The plasmids expressing dominant-negative forms of CREB (25), ATF-1 (25), and the constitutive repressor I{kappa}B{Delta}N (11) have been described previously. The plasmid pSRE-Luc has five serum response element (SRE) domains upstream of a luciferase reporter gene driven by a basic promoter element (Stratagene, La Jolla, CA) and the plasmid expressing dominant-negative form of Elk-1 was provided by Dr. P. Shaw (26).

The plasmids pEgr1-chloramphenicol acetyl transferase (CAT) with full length egr-1 promoter, -606 to -7 bp of the putative transcription start site and various deletions of the egr-1 promoter, -480, -387, -235, and -180 bp cloned into the pCAT vector have been described (27). The region from -606 to -7 bp of the egr-1 promoter, amplified with the Egr-1 forward and reverse primers (Table IGo), was subcloned into KpnI and HindIII sites of the vector pGL3 basic (Promega, Madison WI) and designated pEgr1(-600)Luc. The human egr-1 promoter contains an SRE site (SRE-1) from nucleotides -418 to -391 (27). Plasmids containing site specific mutations in the left Ets binding site (EBS-Lm), right EBS (EBS-Rm), and CArG (CArGm) domains of SRE-1 were constructed in pEgr1(-600)Luc using the site directed mutagenesis kit from Clontech Laboratories (Palo Alto, CA) and the forward EBS-Lm, EBS-Rm, or CArGm primers and the reverse trans AlwnI/SpeI primer (Table IGo). All constructs were analyzed by restriction digests and by sequencing (on an ABI Prism 377XL automated DNA sequencer at the University of Chicago Cancer Center DNA Sequencing Facility, Chicago, IL).


View this table:
[in this window]
[in a new window]
  		Table I. Oligonucleotides used in this study

 
Northern analysis

RAW264.7 cells were cultured at 0.35–0.4 x 106/ml in 6-well plates (4.0 ml/well) for 16–20 h and were stimulated as indicated in the figure. Total RNA was prepared using the RNeasy Purification kit (Qiagen, Valencia, CA). Ten micrograms of total RNA from each sample was separated on 1% agarose formaldehyde gel, and transferred to Hybond nylon membrane (Amersham, Arlington Heights, IL). The probe used was a 3.2-kb EcoRI fragment from the Egr-1 cDNA clone zif/268 (ATCC 63027). The fragment was purified from an agarose gel using the QIAquick PCR purification kit (Qiagen), labeled with 32P using the random primer labeling method (28) and purified on ChromaSpin columns (Clontech Laboratories). Prehybridization, hybridization, and washes were performed as before (12). The blots were stripped and reprobed with GAPDH as a control, obtained by polymerase chain reaction using total RNA as template and with primers described before (11).

EMSAs

Cells were cultured at 0.35–0.4 x 106/ml in 24-well plates (1.0 ml/well) for 16–20 h and stimulated as indicated in the figures. Nuclear extracts were prepared as before (8). Five micrograms of nuclear proteins were incubated with 32P-labeled oligonucleotides for 30 min at 22°C as described before (8). All samples were then separated on 6% nondenaturing polyacrylamide gels and the DNA-protein complexes were visualized by autoradiography. Double stranded oligonucleotides with sequences homologous to human tnf-{alpha} promoter (CRE, Egr-1, and {kappa}B3) or egr-1 promoter (SRE-1) and containing binding sites for the indicated transcription factors are listed in Table IGo. To show specificity of binding to SRE-1 nuclear extracts were preincubated for 10 min at 22°C in the presence of 50-fold excess of unlabeled self oligonucleotide. For supershift experiments, 1 µg of Ab was preincubated with nuclear extracts for 10 min for Egr-1 and 20 min for all other transcription factors, before the addition of the labeled oligonucleotide. Abs against NF-{kappa}B p50 and p65 and CREB were from Upstate Biotechnology (Lake Placid, NY) and all other Abs were from Santa Cruz Biotechnology (Santa Cruz, CA).

Phosphorylation of Elk-1 and Western blots

RAW264.7 cells were seeded at 0.35–0.4 x 106/ml in 24-well plates (1 ml/well) and cultured for 16–20 h. Cells were activated with the stimulants as indicated in the figures and then washed and lysed as before (12). Cell lysates were separated on 12% SDS-PAGE and transferred to Immobilon P (12). Phosphorylation of Elk-1 protein was determined by Western blotting with 0.5 µg/ml rabbit anti-pElk-1 Ab (Santa Cruz Biotechnology), and detected by the ECL system. This Ab specifically recognizes the Elk-1 protein phosphorylated at serine 383. Control blots were done with 0.5 µg/ml anti-Elk-1 (Santa Cruz Biotechnology) which recognizes the nonphosphorylated form of Elk-1.

Transfection and CAT and luciferase assays

RAW264.7 cells were cultured at 0.35–0.4 x 106/ml in 48-well plates (0.5 ml/well) for 16–20 h and transfected with 200 µg/ml DEAE-dextran and 1 µg/ml DNA (optimal concentration) (25). In cotransfection experiments, when dominant-negative or mutant plasmids were not used, equivalent amounts of appropriate control vectors were included and, in addition, the total DNA concentration was brought up to 2.5 µg/ml with salmon sperm DNA. All plasmid DNA was prepared using the endotoxin-free DNA kit (Qiagen). Cells were allowed to recover for 24–48 h and then were left unstimulated or were stimulated as described in the figures. Lysates were prepared and assayed for luciferase activity using the Luciferase Reporter kit (Promega) and the Reporter Microplate Luminometer (Turner Instruments, Sunnyvale, CA), or for CAT activity as described (25).


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
sPGN-induced activation of tnf-{alpha} promoter requires CRE, Egr-1, and {kappa}B3 binding sites and transcription factors c-Jun, Egr-1, and NF-{kappa}B, but not CREB and ATF-1

To identify the transcription factors that regulate the expression of tnf-{alpha} in cells stimulated with bacterial cell wall components, we first tested activation of a tnf-{alpha} promoter construct, in macrophages transiently transfected with the plasmid pTNF(-615)Luc. This plasmid has 615 bp of the tnf-{alpha} promoter placed directly upstream of the luciferase coding region and the promoter activity is assayed based on the amount of luciferase produced. sPGN and LPS induced tnf-{alpha} promoter activity by an average of 6.3- and 8.9-fold, respectively, over unstimulated cells (Fig. 1GoA). The increase in transcription in these cells is accompanied by an increase in the amount of TNF-{alpha} secreted (Fig. 1GoB). To identify the regions of the tnf-{alpha} promoter that are involved in the regulation of transcription, we next analyzed the activity of constructs with serial deletions in the tnf-{alpha} promoter. In cells stimulated with sPGN, transcription of tnf-{alpha} gene was regulated by sequences in the region between -615 and -295 bp, and by sequences proximal to -182 bp (Fig. 1GoC). The deletion between -615 and -295 bp reduced transcriptional induction of tnf-{alpha} in sPGN stimulated cells by 50% (Fig. 1GoC), which indicates that sequences within this region are required for full induction of tnf-{alpha} in sPGN-stimulated cells. The loss of sequences between -182 and -95 further reduced tnf-{alpha} induction to levels that are no higher than unstimulated samples (Fig. 1GoC). By contrast, in cells stimulated with ReLPS, only sequences proximal but not distal to -182 bp contain regulatory elements that were required for transcriptional induction of tnf-{alpha} (Fig. 1GoC).



View larger version (31K):
[in this window]
[in a new window]
  		FIGURE 1. sPGN induces transcription of tnf-{alpha} gene and secretion of TNF-{alpha}, and transcriptional induction requires binding sites CRE, Egr-1, and {kappa}B3. RAW264.7 cells were transfected with pTNF(-615)Luc or empty vector pXP1 (A); the indicated deleted promoter constructs or empty vector pXP1 (C); tnf-{alpha} promoter mutants (D); and pTNF(-615)Luc plus dominant-negative forms of ATF-1, CREB, or the constitutive repressor I{kappa}B{Delta}N (E). A and C–E, Cells were stimulated with sPGN or LPS and cell lysates were assayed for luciferase activity. B, RAW264.7 cells were stimulated with sPGN or LPS or left unstimulated for 16 h and supernatants were assayed for TNF-{alpha}. The results are means of duplicate samples from one of three similar experiments (A); means of three experiments (B); and means of the percentage of pTNF(-615)Luc activity (C and D) or the percentage of control vector from three experiments (E). The percent of control vector = (mean cpm stimulated with dominant negative - mean cpm unstimulated with dominant negative) x 100/(mean cpm stimulated with empty vector - mean cpm unstimulated with empty vector).

 
We next identified specific sequences that are required for tnf-{alpha} induction in sPGN-stimulated cells. In this study, we focused on the region between -182 and -95 bp. We are currently analyzing the region between -615 and -295 bp and the results will be presented separately. However, we do know that the NF-{kappa}B site at -587 bp is not involved in transcriptional induction of tnf-{alpha} in sPGN-stimulated cells (data not shown). The region proximal of -182 bp contains binding sites for several different transcription factors, including an Egr-1 site at -172 bp, a CRE site at -106 bp, a {kappa}B3 site at -97, and an AP-1 site at -66 bp. To determine whether these sites are required for tnf-{alpha} induction in sPGN-stimulated cells, we tested for tnf-{alpha} promoter activity using promoter-luciferase construct with site specific mutations in the binding sites for these transcription factors. Mutations within the CRE, Egr-1, and {kappa}B3, but not the AP-1 site, greatly reduced tnf-{alpha} induction for both sPGN- and LPS-stimulated cells (Fig. 1GoD). To confirm the role of specific transcription factors in the regulation of tnf-{alpha} expression, we tested the effect of dominant-negative forms of the transcription factors ATF-1 and CREB and a constitutive repressor of the inhibitory protein I{kappa}B, I{kappa}B{Delta}N. Dominant-negative ATF-1 and CREB did not inhibit tnf-{alpha} promoter activity in sPGN- or LPS-stimulated cells (Fig. 1GoE). These results along with the data in Fig. 1GoD indicate that the CRE site on the tnf-{alpha} promoter is required for tnf-{alpha} induction; however, the transcription factors ATF-1 and CREB are not involved in this induction. The constitutive repressor I{kappa}B{Delta}N strongly inhibited tnf-{alpha} induction (Fig. 1GoE), which confirms the role for NF-{kappa}B in tnf-{alpha} transcription in sPGN- and LPS-activated macrophages.

To determine whether proteins from sPGN- and LPS-stimulated nuclear extracts bind to the CRE, Egr-1, and {kappa}B3 sites on the tnf-{alpha} promoter, we performed EMSAs. Oligonucleotides homologous to the region of the tnf-{alpha} promoter containing binding sites for CRE, Egr-1, and {kappa}B3 were used for these assays. Both sPGN and LPS induced time-dependent binding to the CRE, Egr-1, and {kappa}B3 sites (Fig. 2Go, A–C). We next determined by supershift assays which nuclear proteins from sPGN- and LPS-stimulated macrophages bound these motifs. The CRE sequence can bind a variety of dimers from the CRE/ATF and the AP-1 family of transcription factors and we tested Abs against CREB, ATF-1, and c-Jun. Abs against c-Jun, but not against CREB and ATF-1, decreased binding of proteins to the CRE oligonucleotide, indicating that c-Jun protein, but not CREB and ATF-1 proteins, bind CRE. Abs against CREB and ATF-1 do have the capacity to bind to the appropriate transcription factors and induce inhibition of binding to appropriate oligonucleotides or supershift of the oligonucleotide-protein complexes (25).



View larger version (33K):
[in this window]
[in a new window]
  		FIGURE 2. sPGN induces binding of c-Jun, Egr-1, and NF-{kappa}B to tnf-{alpha}promoter. RAW264.7 cells were stimulated with sPGN or LPS and nuclear extracts were incubated with radioactively labeled oligonucleotides homologous to the tnf-{alpha} promoter with binding sites for CRE (A), Egr-1 (B), and {kappa}B3 (C). For supershift experiments, nuclear extracts were preincubated with the indicated Abs. The results are from one of two similar experiments.

 
An Ab to Egr-1 decreased binding of nuclear proteins to the Egr-1 motif from both sPGN- and LPS-stimulated nuclear extracts (Fig. 2GoB). To identify the proteins bound to the {kappa}B3 site, we tested Abs against p50, p65, and c-rel. Abs against p50 and p65 supershifted the protein-DNA complex (Fig. 2GoB). These results indicate that both sPGN and LPS stimulation induces binding of the proteins c-Jun, Egr-1, and NF-{kappa}B p50 and p65 to the CRE, Egr-1, and {kappa}B3 sites, respectively, on the tnf-{alpha} promoter.

To determine whether the same transcription factors are similarly activated by sPGN in human monocytes, we performed EMSAs with nuclear extracts from the human monocytic cell line THP-1/hCD14. Nuclear proteins from both sPGN- and LPS-stimulated cells induced time-dependent binding to the CRE, Egr-1, and {kappa}B3 sites (Fig. 3Go).



View larger version (60K):
[in this window]
[in a new window]
  		FIGURE 3. sPGN induces binding of proteins to the CRE, Egr-1, and {kappa}B3 sites in human monocytic THP-1 cells. THP-1/hCD14 were stimulated with sPGN or LPS and nuclear extracts were incubated with radioactively labeled oligonucleotides homologous to the tnf-{alpha} promoter with binding sites for CRE, Egr-1, and {kappa}B3.

 
sPGN and Micrococci induce transcription of egr-1 gene and this induction requires SRE-1 sequence

Our results show that tnf-{alpha} induction in sPGN-stimulated macrophages is regulated by the transcription factors c-Jun, Egr-1, and NF-{kappa}B. We have previously studied the activation and regulation of c-Jun (25) and NF-{kappa}B (11); therefore, we investigated regulation of Egr-1 in this study. Macrophages activated with sPGN and Micrococci showed time-dependent induction of egr-1 transcription; levels of egr-1 transcripts increased within 15 min and reached a maximum by 30 min (Fig. 4GoA). LPS, as shown previously (29), also induced expression of the egr-1 gene. To determine the regulation of egr-1 transcription in sPGN-stimulated macrophages, we first constructed and tested the expression of an egr-1 promoter luciferase plasmid, pEgr1(-600)Luc, in macrophages transiently transfected with the plasmid. This plasmid contains -606 to -7 bp of the egr-1 promoter fused directly upstream of the coding sequence for luciferase. sPGN and LPS induced egr-1 promoter activity by an average of 5.5- and 5.7-fold, respectively, over unstimulated cells (Fig. 4GoB). To identify regulatory elements within the egr-1 promoter that are required for sPGN- and LPS-induced transcription of the gene, we next analyzed the expression of deletion constructs. A deletion from -600 to -480 bp resulted in a slight increase in egr-1 promoter activity, however, a deletion from -480 to -387 bp reduced sPGN- and LPS-induced egr-1 transcription by 77 and 86%, respectively (Fig. 4GoC). Further deletions of the egr-1 promoter did not result in any additional significant changes of sPGN- and LPS-induced egr-1 transcription (Fig. 4GoC). Our results indicate that sequences between -480 and -387 bp of the egr-1 promoter are required for sPGN- and LPS-induced expression of the egr-1 gene.



View larger version (54K):
[in this window]
[in a new window]
  		FIGURE 4. sPGN, LPS, and Micrococci induce transcription of egr-1 gene and this induction requires sequences from -480 to -387 nucleotides in egr-1 promoter. A, RAW264.7 cells were stimulated with sPGN, LPS, or Micrococci, and total RNA was analyzed for Egr-1 transcripts by Northern blots. B and C, RAW264.7 cells were transfected with pEgr1(-600)Luc or empty vector pGL3 (B), and pEgr1(-600)Luc or the indicated deleted constructs (C). Cells were stimulated and cell lysates were assayed as described in Fig. 1Go. The results for A are from one of two similar experiments; the results of B are means of duplicate samples from one of three similar experiments; and the results of C were calculated as in Fig. 1GoD and are means from two experiments.

 
The region between -480 and -387 bp of the egr-1 promoter contains SRE-1 from -418 to -391 bp with a core CArG box and EBS on either side. To determine whether SRE-1 is required for sPGN- and LPS-induced egr-1 transcription, we introduced site specific mutations within the SRE-1 domain of pEgr1(-600)Luc. We constructed plasmids with mutations within the CArG box and either of the two flanking EBSs, called CArGm, EBS-Lm, and EBS-Rm recepectively (Fig. 5GoA). All three mutants showed a decrease in the induction of egr-1 expression, with the greatest loss caused by the mutation in the EBS sequence on the right of the CArG box in both sPGN- and LPS-stimulated cells (Fig. 5GoB).



View larger version (23K):
[in this window]
[in a new window]
  		FIGURE 5. sPGN- and LPS-induced expression of egr-1 gene requires SRE-1 binding site. A, Sequences of the wild type and mutant SRE-1. B, RAW264.7 cells were transfected with wild type or mutant pEgr1(-600)Luc DNA. Cells were stimulated and cell lysates were assayed as described in Fig. 1Go. The results are means from two experiments.

 
To identify proteins from sPGN-stimulated cells that bind the SRE-1 domain on the egr-1 promoter, we did gel shift assays using an oligonucleotide homologous to this region of the egr-1 promoter. Nuclear proteins from sPGN- or LPS-stimulated or unstimulated macrophages (Fig. 6Go) bound the SRE-1 domain resulting in the formation of at least five different DNA complexes. These protein-DNA complexes were specific for SRE-1 as unlabeled SRE-1 oligonucleotide completely eliminated the formation of these complexes with the labeled SRE-1 (Fig. 6Go). Abs against Elk-1, a member(s) of the Ets family of transcription factors, and against serum response factor (SRF) supershifted or reduced binding of one or more of the protein-DNA complexes (Fig. 6Go), which indicates that these transcription factors bind SRE-1. Higher concentrations of these Abs had the same effect. These results indicate that SRE-1 is required for sPGN- and LPS-induced expression of the egr-1 gene and this induction may be mediated by the transcription factors SRF and Elk-1.



View larger version (72K):
[in this window]
[in a new window]
  		FIGURE 6. sPGN and LPS induce binding of Elk-1 and SRF to SRE-1 region of egr-1 promoter. RAW264.7 cells were stimulated or left unstimulated and nuclear extracts were prepared and incubated with radioactively labeled oligonucleotide homologous to the SRE-1 region of the egr-1 promoter in the presence and absence of excess unlabeled self competitor oligonucleotide. In supershift experiments nuclear extracts were preincubated with the indicated Abs, and assayed as in Fig. 2Go. The arrows indicate the shift in the DNA-protein complexes upon Ab binding. The results are from one of three similar experiments.

 
sPGN induces phosphorylation and activation of Elk-1, and dominant-negative Elk-1 inhibits sPGN-induced transcription of egr-1 gene

Elk-1 is activated by phosphorylation at several different serine residues, including serine 383. To determine whether sPGN and LPS induce phosphorylation of Elk-1, we used an Ab that specifically recognizes Elk-1 phosphorylated at S383. In these experiments we also tested Micrococcus as a prototypic, Gram-positive bacterium. All three stimulants induced rapid but transient phosphorylation of Elk-1 (Fig. 7GoA, upper panel). Identical samples analyzed with an Ab against both phosphorylated and nonphosphorylated Elk-1 showed equal amounts of the protein in all lanes (Fig. 7GoA, lower panel). To determine whether phosphorylation results in functional activation of Elk-1, we tested the expression of a reporter plasmid that is regulated by SRE domains, pSRE-Luc. Both sPGN and LPS induced luciferase activity by 6.8- and 4.6-fold, respectively, in cells transfected with pSRE-Luc (Fig. 7GoB), and this induction was inhibited 80 and 50%, respectively, by dominant-negative Elk-1 (Fig. 7GoC). These results indicate that the induction of SRE activity in sPGN-stimulated cells is mostly due to Elk-1, whereas, the induction in LPS-simulated cells is only in part due to Elk-1. To confirm that sPGN- and LPS-induced expression of egr-1 is regulated by Elk-1, we tested the effect of dominant-negative Elk-1 on the expression of egr-1 in sPGN- and LPS-stimulated cells. Dominant-negative Elk-1 inhibited egr-1 induction by 70% in both sPGN- and LPS-stimulated cells (Fig. 7GoD). These results indicate that increased expression of the egr-1 gene in macrophages stimulated with sPGN and LPS is regulated by the SRE-1 domain the egr-1 promoter and that the transcription factor Elk-1 is in part responsible for this activation.



View larger version (39K):
[in this window]
[in a new window]
  		FIGURE 7. sPGN and LPS induce phosphorylation of Elk-1, and dominant-negative Elk-1 inhibits transcription of egr-1 gene. A, RAW264.7 cells were stimulated as in Fig. 3Go and cell lysates were separated by SDS-PAGE and analyzed by Western Blots for phosphorylation of Elk-1 using an anti-phosphorylated Elk-1 Ab or total (phosphorylated and nonphosphorylated) Elk-1 protein using an anti-Elk-1 Ab. The results are from one of three similar experiments. B–D, RAW264.7 cells were transfected with pSRE-Luc or empty vector pCMV (B), pSRE-Luc and dominant-negative Elk-1 or its control vector (C), and pEgr1(-600)Luc and dominant-negative Elk-1 or its control vector (D). The results for B are means of duplicate samples from one of three similar experiments; the results for C and D were calculated as for Fig. 1GoD and are means from two experiments.

 

   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
Our results demonstrate that sPGN-induced transcription of tnf-{alpha} in macrophages is regulated by the sequences between -615 and -295 bp and by the sequences proximal to -182 bp on the tnf-{alpha} promoter. In the proximal region, the CRE (-106 bp) sequence is required for tnf-{alpha} induction and binds the transcription factor c-Jun but does not bind CREB or ATF-1. c-Jun binds CRE sequences preferentially as Jun-ATF heterodimers (30) and transactivation of tnf-{alpha} may involve members of the ATF family other than ATF-1. The Egr-1 (-169 bp) and {kappa}B3 (-97 bp) domains bind proteins Egr-1 and NF-{kappa}B p50 and p65, respectively, and are also required for sPGN-induced expression of the tnf-{alpha} gene. The requirement for NF-{kappa}B is further confirmed by the inhibition of tnf-{alpha} activation by a constitutive repressor of I{kappa}B, I{kappa}B{Delta}N. Further confirmation of the requirement for c-Jun and Egr-1 for increased transcription of tnf-{alpha} in sPGN-activated macrophages, by transfecting RAW264.7 cells with two different constructs for dominant-negative c-Jun (31, 32) and with one construct of dominant-negative Egr-1 (33), was not feasible, because we were unable to express either of these proteins in these cells. A deletion of the tnf-{alpha} promoter from -615 to -295 bp reduces sPGN-induced tnf-{alpha} expression by ~50%. An NF-{kappa}B-binding domain at -587 bp does not bind proteins from sPGN-stimulated nuclear extracts (data not shown). We are currently analyzing this region in greater detail to identify the role of known and novel transcription factors in the regulation of tnf-{alpha} expression.

Our data showing that LPS-induced expression of tnf-{alpha} requires intact binding sites of CRE, Egr-1, and {kappa}B3 and the proteins c-Jun, Egr-1, and NF-{kappa}B are in agreement with a previously published report (18); however, the requirement of NF-{kappa}B is inconsistent with the data shown by other investigators (34). Our results also indicate that induction of tnf-{alpha} in LPS-activated macrophages does not require the region -615 to -182 bp, which is consistent with the previous study (18); however, it is in contrast to other data showing the presence and the requirement for NF-{kappa}B sites (16) and an LPS-induced TNF-{alpha} factor site (17) in the distal region of the promoter. The reasons for these discrepancies are not completely understood, but they may be due in part to the different cells used in these studies.

Our data indicate that sPGN-induced expression of tnf-{alpha} requires transcription factors that belong to the AP-1 family and requires Egr-1 and NF-{kappa}B proteins. Because we have previously investigated the activation of CREB (25), AP-1 (25), and NF-{kappa}B (8, 11), in this study we have focused on the activation of Egr-1 to identify potential novel regulatory pathway(s) that are involved in the activation of tnf-{alpha} expression in sPGN-simulated macrophages.

Our data show that Egr-1 mRNA is rapidly induced in RAW264.7 cells stimulated with sPGN, LPS, and Micrococci and are consistent with the results of other investigators showing induction of egr-1 in macrophages stimulated by LPS (29). The induction for both sPGN and LPS is completely dependent on the sequences within the region of -480 to -387 bp of the egr-1 promoter. This region contains a single SRE (SRE-1) from nucleotides -418 to -391, with a core CArG sequence and EBS on either side. The CArG domain consists of 10 nucleotides with the following sequence 5'-CC(A/T)6GG-3' and binds SRF (35). The EBS has the sequence 5'-C/AGGAA/TT-3' and binds proteins from the Ets family of transcription factors. SRF protein binds SRE as a dimer and forms a ternary complex with members of the Ets family, and this complex transactivates genes in response to a variety of stimulants, including growth factors and serum (35, 36, 37, 38). We have shown that SRE-1 is required for both sPGN- and LPS-induced expression of egr-1, and that the 3' EBS may have a greater role than the 5' EBS in protein binding and transactivation.

The SRE-1 domain binds the proteins Elk-1 and SRF and upon stimulation with sPGN and LPS this complex may induce transcription of the egr-1 gene. Elk-1 is strongly phosphorylated at S383 in sPGN-, LPS-, and Micrococci-stimulated cells, which provides further evidence for the role of Elk-1 in transcription of egr-1. sPGN and LPS induce expression of a luciferase reporter gene that is regulated by SRE domains, and this expression is inhibited by a dominant-negative form of Elk-1, which confirmed that Elk-1 is functionally active in stimulated cells. Furthermore, dominant-negative Elk-1 inhibited sPGN- and LPS-induced expression of egr-1 gene, which confirms that Elk-1 is required for the expression of Egr-1.

We have demonstrated that sPGN-induced expression of tnf-{alpha} gene in macrophages requires the binding sites CRE, Egr-1, and {kappa}B3, and is mediated directly through the transcription factors c-Jun, Egr-1, and NF-{kappa}B. The expression of egr-1 gene in stimulated macrophages is regulated by the transcription factor Elk-1; therefore, tnf-{alpha} transcription is regulated indirectly through Elk-1. sPGN activates the MAP kinases ERK and JNK (12, 20), and this is consistent with the phosphorylation and activation of c-Jun, which we have previously demonstrated (25), and with the phosphorylation and activation of Elk-1 shown in this study.

We have also previously shown that NF-{kappa}B is activated through the TLR2->MyD88->IRAK->TRAF6->NIK->IKK signal transduction pathway (11). These results suggest that sPGN-induced expression of tnf-{alpha} may be mediated through both the Ras/Rac->MAP kinase and the MyD88->IRAK->TRAF6->NIK->IKK pathways, which is consistent with the activation of both pathways through the TLR receptors (11, 39, 40). PGN and LPS induce similar, but not identical, genes in monocytes (10), and moreover, they induce differential activation of MAP kinases in macrophages (20). Therefore, these results also suggest that similar, although not necessarily identical, pathways are activated through TLR2 and TLR4 receptors, which are selectively activated by PGN and LPS, respectively (5, 6, 39, 40, 41, 42, 43). Although the current study did not reveal any major differences in the transcription factors induced by PGN and LPS, it did show differential effects of distinct regions in the tnf-{alpha} promoter on PGN- and LPS-induced activation of tnf-{alpha} gene. The role of these regions in the differences in TLR2- and TLR4-induced signals will require further study.


   Acknowledgments
 
We thank Drs. James Economou, Nigel Mackman, and Peter Shaw for providing us with several plasmids (listed in Materials and Methods), and Peter S. Tobias for the THP-1/hCD14 cell line.


   Footnotes
 
1 This work was supported by National Institutes of Health Grants AI28797 (to R.D. and D.G.) and R29CA68221 (to K.M.S.), and the American Cancer Society Grant RPG-99-081-01-LBC (to K.M.S.). K.M.S. is a scholar of the Leukemia and Lymphoma Society. Back

2 Current address: Washington University School of Medicine, St. Louis, MO 63310. Back

3 Address correspondence and reprint requests to Dr. Dipika Gupta, Northwest Center for Medical Education, Indiana University School of Medicine, 3400 Broadway, Gary, IN 46408. E-mail address: dgupta{at}iun.edu Back

4 Abbreviations used in this paper: PGN, peptidoglycan; AP, activating protein; ATF, activating transcription factor; CAT, chloramphenicol acetyl transferase; CRE, cAMP response element; Egr, early growth response; ERK, extracellular signal-regulated kinase; IRAK, IL-1R-associated kinase; IKK, I{kappa}B kinase; JNK, c-Jun N-terminal kinase; MAP, mitogen-activated protein; MyD88, myeloid differentiation protein; NIK, NF-{kappa}B-inducing kinase; sPGN, soluble PGN; SRE, serum response element; SRF, serum response factor; TLR, Toll-like receptor; TRAF, TNFR associated kinase; EBS-Lm, mutation in the left Ets binding site; EBS-Rm, mutation in the right EBS; CArGm, mutation in CArG. Back

Received for publication July 31, 2001. Accepted for publication October 11, 2001.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Medzhitov, R., Jr C. A. Janeway. 1998. An ancient system of host defense. Curr. Opin. Immunol. 10:12.[Medline]
  2. Hoffman, J. A., F. C. Kafatos, Jr C. A. Janeway, R. A. B. Ezekowitz. 1999. Phylogenetic perspectives in innate immunity. Science 284:1313.[Abstract/Free Full Text]
  3. Dziarski, R., A. J. Ulmer, D. Gupta. 2000. Interactions of CD14 with components of Gram-positive bacteria. Chem. Immunol. 74:83.[Medline]
  4. Dziarski, R., A. J. Ulmer, D. Gupta. 2000. Interactions of bacterial lipopolysaccharide and peptidoglycan with mammalian CD14. R. J. Doyle, ed. Glycomicrobiology 145. Kluwer Academic/Plenum Publishers, New York.
  5. Schwandner, R., R. Dziarski, H. Wesche, M. Rothe, C. J. Kirschning. 1999. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2. J. Biol. Chem. 274:17406.[Abstract/Free Full Text]
  6. Yoshimura, A., E. Lien, R. R. Ingalls, E. Tuomanen, R. Dziarski, D. Golenbock. 1999. Recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. Immunol. 163:1.[Abstract/Free Full Text]
  7. Weidemann, B., H. Brade, E. T. Rietschel, R. Dziarski, V. Bazil, S. Kusumoto, H.-D. Flad, A. J. Ulmer. 1994. Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures. Infect. Immun. 62:4709.[Abstract/Free Full Text]
  8. Gupta, D., T. N. Kirkland, S. Viriyakosol, R. Dziarski. 1996. CD14 is a cell-activating receptor for bacterial peptidoglycan. J. Biol. Chem. 271:23310.[Abstract/Free Full Text]
  9. Dziarski, R., R. I. Tapping, P. S. Tobias. 1998. Binding of bacterial peptidoglycan to CD14. J. Biol. Chem. 273:8680.[Abstract/Free Full Text]
  10. Wang, Z.-M., C. Liu, R. Dziarski. 2000. Chemokines are the main pro-inflammatory mediators in human monocytes activated by Staphylococcus aureus, peptidoglycan, and endotoxin. J. Biol. Chem. 275:20260.[Abstract/Free Full Text]
  11. Wang, Q., R. Dziarski, C. J. Kirschning, M. Muzio, D. Gupta. 2001. Micrococci and peptidoglycan activate TLR2->MyD88->IRAK->TRAF->NIK->IKK->NF-{kappa}B signal transduction pathway that induces transcription of interleukin-8. Infect. Immun. 69:2270.[Abstract/Free Full Text]
  12. Gupta, D., Y. Jin, R. Dziarski. 1995. Peptidoglycan induces transcription and secretion of TNF-{alpha} and activation of Lyn, extracellular signal-regulated kinase, and Rsk signal transduction proteins in mouse macrophages. J. Immunol. 155:2620.[Abstract]
  13. Beutler, B.. 1992. Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine Raven Press, New York.
  14. Han, J., T. Brown, B. Beutler. 1990. Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J. Exp. Med. 171:465.[Abstract/Free Full Text]
  15. Raabe, T., M. Bukrinsky, R. A. Currie. 1998. Relative contribution of transcription and translation to the induction of tumor necrosis factor-{alpha} by lipopolysaccharide. J. Biol. Chem. 273:974.[Abstract/Free Full Text]
  16. Udalova, I. A., J. C. Knight, V. Vidal, S. A. Nedospasov, D. Kwiatkowski. 1998. Complex NF-{kappa}B interactions at the distal tumor necrosis factor promoter region in human monocytes. J. Biol. Chem. 273:21178.[Abstract/Free Full Text]
  17. Myokai, F., S. Takashiba, R. Lebo, S. Amar. 1999. A novel lipopolysaccharide-induced transcription factor regulating tumor necrosis factor {alpha} gene expression: molecular cloning, sequencing, characterization, and chromosomal assignment. Proc. Natl. Acad. Sci. USA 96:4518.[Abstract/Free Full Text]
  18. Yao, J., N. Mackman, T. S. Edgington, S. T. Fan. 1997. Lipopolysaccharide induction of the tumor necrosis factor-{alpha} promoter in human monocytic cells: regulation by Egr-1, c-Jun, and NF-{kappa}B transcription factors. J. Biol. Chem. 272:17795.[Abstract/Free Full Text]
  19. Steer, J. H., K. M. Kroeger, L. J. Abraham, D. A. Joyce. 2000. Glucocorticoids suppress tumor necrosis factor-{alpha} expression by human monocytic THP-1 cells by suppressing transactivation through adjacent NF-{kappa}B and c-Jun-activating transcription factor-2 binding sites in the promoter. J. Biol. Chem. 275:18432.[Abstract/Free Full Text]
  20. Dziarski, R., Y. Jin, D. Gupta. 1996. Differential activation of extracellular signal-regulated kinase (ERK) 1, ERK2, p38, and c-Jun NH2-terminal kinase mitogen-activated protein kinases by bacterial peptidoglycan. J. Infect. Dis. 174:777.[Medline]
  21. Karin, M.. 1995. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270:16483.[Free Full Text]
  22. Gashler, A., V. P. Sukhatme. 1995. Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. Proc. Nucleic Acid Res. Mol. Biol. 50:191.
  23. Rosenthal, R. S., R. Dziarski. 1994. Isolation of peptidoglycan and soluble peptidoglycan fragments. Methods Enzymol. 235:253.[Medline]
  24. Economou, J. S., K. Rhoades, R. Essner, W. H. McBride, J. C. Gasson, D. L. Morton. 1989. Genetic analysis of the human tumor necrosis factor {alpha}/cachectin promoter region in a macrophage cell line. J. Exp. Med. 170:321.[Abstract/Free Full Text]
  25. Gupta, D., Q. Wang, C. Vinson, R. Dziarski. 1999. Bacterial peptidoglycan induces CD14-dependent activation of transcription factors CREB/ATF and AP-1. J. Biol. Chem. 274:14012.[Abstract/Free Full Text]
  26. Kortenjann, M., P. Shaw. 1995. Raf-1 kinase and ERK2 uncoupled from mitogenic signals in rat fibroblasts. Oncogene 11:2105.[Medline]
  27. Mora-Garcia, P., K. M. Sakamoto. 2000. Granulocyte colony-stimulating factor induces Egr-1 up-regulation through interaction of serum response element-binding proteins. J. Biol. Chem. 275:22418.[Abstract/Free Full Text]
  28. Sambrook, J., D. W. Russell. 2001. Molecular Cloning Cold Spring Harbor Lab. Press, Cold Spring Harbor, NY.
  29. Coleman, D. L., A. H. Bartiss, V. P. Sukhatme, J. Liu, H. D. Rupprecht. 1992. Lipopolysaccharide induces Egr-1 mRNA and protein in murine peritoneal macrophages. J. Immunol. 149:3045.[Abstract]
  30. Karin, M., Z.-G. Liu, E. Zandi. 1997. AP-1 function and regulation. Curr. Opin. Cell Biol. 9:240.[Medline]
  31. Lloyd, A., N. Yancheva, B. Wasylyk. 1991. Transformation suppressor activity of a Jun transcription factor lacking its activation domain. Nature 352:635.[Medline]
  32. Min, W., J. S. Pober. 1997. TNF initiates E-selectin transcription in human endothelial cells through parallel TRAF-NF-{kappa}B and TRAF-RAC/CDC42-JNK-c-Jun/ATF2 pathways. J. Immunol. 159:3508.[Abstract]
  33. Rauscher, F. J., J. F. Morris, O. E. Tournay, D. M. Cook, T. Curran. 1990. Binding of the Wilms’ tumor locus zinc finger protein to the EGR-1 consensus sequence. Science 250:1259.[Abstract/Free Full Text]
  34. Goldfeld, A. E., C. Doyle, T. Maniatis. 1990. Human tumor necrosis factor {alpha} gene regulation by virus and lipopolysaccharide. Proc. Natl. Acad. Sci. USA 87:9769.[Abstract/Free Full Text]
  35. Wasylyk, B., and A. Nordheim. 1997. Transcription Factors in Eukaryotes. A. G. Papavassiliou, ed. Chapman and Hall, New York.
  36. Shaw, P. E., H. Schroter, A. Nordheim. 1989. The ability of a ternary complex to form over the serum response element correlates with serum inducibility of the human c-fos promoter. Cell 56:563.[Medline]
  37. Marais, R., J. Wyne, R. Treisman. 1993. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 73:381.[Medline]
  38. Wasylyk, B., J. Hagman, A. Gutierrez-Hartman. 1998. Ets transcription factors: nuclear effectors of the Ras-MAP-kinase signaling pathway. Trends Biochem. Sci. 23:213.[Medline]
  39. Aderem, A., R. J. Ulevitch. 2000. Toll-like receptors in the induction of the innate immune response. Nature 406:782.[Medline]
  40. Arbibe, L., J. P. Mira, N. Teusch, L. Kline, M. Guha, N. Mackman, P. J. Godowski, R. J. Ulevitch, U. G. Knaus. 2000. Toll-like receptor 2-mediated NF-{kappa}B activation requires a Rac1-dependent pathway. Nature Immunol. 1:533.[Medline]
  41. Poltorak, A., X. He, I. Smirnova, M.-Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, et al 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085.[Abstract/Free Full Text]
  42. Takeuchi, O., K. Hoshino, T. Kawai, H. Sanjo, H. Takada, T. Ogawa, K. Takeda, S. Akira. 1999. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 11:443.[Medline]
  43. Dziarski, R., Q. Wang, K. Miyake, C. J. Kirschning, D. Gupta. 2001. MD-2 enables Toll-like receptor-2 (TLR2)-mediated responses to LPS and enhances TLR2-mediated responses to Gram-positive and Gram-negative bacteria and their cell wall components. J. Immunol. 166:1938.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
X. Li, S. Wang, H. Wang, and D. Gupta
Differential Expression of Peptidoglycan Recognition Protein 2 in the Skin and Liver Requires Different Transcription Factors
J. Biol. Chem., July 28, 2006; 281(30): 20738 - 20748.
[Abstract] [Full Text] [PDF]

Home page
 Innate ImmunityHome page
S. Traub, S. von Aulock, T. Hartung, and C. Hermann
Invited review: MDP and other muropeptides direct and synergistic effects on the immune system
Innate Immunity, April 1, 2006; 12(2): 69 - 85.
[Abstract] [PDF]

Home page
 BloodHome page
B. Li, M. R. Power, and T.-J. Lin
De novo synthesis of early growth response factor-1 is required for the full responsiveness of mast cells to produce TNF and IL-13 by IgE and antigen stimulation
Blood, April 1, 2006; 107(7): 2814 - 2820.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
H. Wang, D. Gupta, X. Li, and R. Dziarski
Peptidoglycan Recognition Protein 2 (N-Acetylmuramoyl-L-Ala Amidase) Is Induced in Keratinocytes by Bacteria through the p38 Kinase Pathway
Infect. Immun., November 1, 2005; 73(11): 7216 - 7225.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
A. R. Suriano, A. N. Sanford, N. Kim, M. Oh, S. Kennedy, M. J. Henderson, K. Dietzmann, and K. E. Sullivan
GCF2/LRRFIP1 Represses Tumor Necrosis Factor Alpha Expression
Mol. Cell. Biol., October 15, 2005; 25(20): 9073 - 9081.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Nadesalingam, A. W. Dodds, K. B. M. Reid, and N. Palaniyar
Mannose-Binding Lectin Recognizes Peptidoglycan via the N-Acetyl Glucosamine Moiety, and Inhibits Ligand-Induced Proinflammatory Effect and Promotes Chemokine Production by Macrophages
J. Immunol., August 1, 2005; 175(3): 1785 - 1794.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. G. Ma, M. Y. Cho, M. Zhao, J. W. Park, M. Matsushita, T. Fujita, and B. L. Lee
Human Mannose-binding Lectin and L-Ficolin Function as Specific Pattern Recognition Proteins in the Lectin Activation Pathway of Complement
J. Biol. Chem., June 11, 2004; 279(24): 25307 - 25312.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M. M. M. Abdel-Latif, H. J. Windle, K. A. Fitzgerald, Y. S. Ang, D. N. Eidhin, M. Li-Weber, K. Sabra, and D. Kelleher
Helicobacter pylori Activates the Early Growth Response 1 Protein in Gastric Epithelial Cells
Infect. Immun., June 1, 2004; 72(6): 3549 - 3560.
[Abstract] [Full Text] [PDF]

Home page